Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(10 sites)
Canada
BC Cancer Agency, Vancouver, British Columbia Lions Gate Hospital, Vancouver, British Columbia William Osler Health System, Brampton, Ontario Hamilton Health Sciences Centre, Juravinski Cancer Centre, Hamilton, Ontario Grand River Regional Cancer Centre, Kitchener, Ontario London Regional Cancer Program of the Lawson Health Research Institute, London, Ontario Durham Regional Cancer Centre, Lakeridge Health, Oshawa, Ontario The Ottawa Hospital, Ottawa, Ontario Sunnybrook Research Institute, Toronto, Ontario Princess Margaret Hospital, Toronto, Ontario Last updated October 2024